Gene · 28695
Papers3,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A high-throughput two-cell assay for interrogating inhibitory signaling pathways in T cells. | Life Sci Alliance | 2024 | 38073578 | PubTator, text mining | PubMed |
| A narrow T cell receptor repertoire instructs thymic differentiation of MHC class Ib-restricted CD8+ regulatory T cells. | J Clin Invest | 2024 | 37934601 | PubTator, text mining | PubMed |
| T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease. | Cell Mol Gastroenterol Hepatol | 2024 | 37714427 | PubTator, text mining | PubMed |
| Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine. | Genes Dis | 2024 | 37588217 | PubTator, text mining | PubMed |
| Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development. | Dev Reprod | 2023 | 38292233 | PubTator, text mining | PubMed |
| Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus. | Front Immunol | 2023 | 38288115 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA). | Vaccines (Basel) | 2023 | 38250827 | PubTator, text mining | PubMed |
| MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection. | Front Immunol | 2023 | 38239352 | PubTator, text mining | PubMed |
| Immunosequencing applications in cutaneous T-cell lymphoma. | Front Immunol | 2023 | 38213330 | PubTator, text mining | PubMed |
| Applications of Genome-Editing Technologies for Type 1 Diabetes. | Int J Mol Sci | 2023 | 38203514 | PubTator, text mining | PubMed |
| Nickel Challenge In Vitro Affects CD38 and HLA-DR Expression in T Cell Subpopulations from the Blood of Patients with Nickel Allergy. | Int J Mol Sci | 2023 | 38203472 | PubTator, text mining | PubMed |
| Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma. | Cells | 2023 | 38201238 | PubTator, text mining | PubMed |
| CD4 and LAG-3 from sharks to humans: related molecules with motifs for opposing functions. | Front Immunol | 2023 | 38187381 | PubTator, text mining | PubMed |
| Attention network for predicting T-cell receptor-peptide binding can associate attention with interpretable protein structural properties. | Front Bioinform | 2023 | 38170146 | PubTator, text mining | PubMed |
| 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells. | bioRxiv | 2023 | 38168221 | PubTator, text mining | PubMed |
| High-throughput sequencing reveals the change of TCR α chain CDR3 with Takayasu arteritis. | Immun Inflamm Dis | 2023 | 38156386 | PubTator, text mining | PubMed |
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation. | Nagoya J Med Sci | 2023 | 38155626 | PubTator, text mining | PubMed |
| CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer. | Front Immunol | 2023 | 38146364 | PubTator, text mining | PubMed |
| Natural Killer T Cell Diversity and Immunotherapy. | Cancers (Basel) | 2023 | 38136283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28695/papers?page=6